drugset / Trial / NCT01980849

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer

NCT01980849

Phase 3 Unknown 272 enrolled Shengqing Li
RandomizedParallel-groupOpen-labelPrevention

Summary

To compare the efficacy and safety of prophylaxis of venous thromboembolism by Nadroparin during hospitalization to long-term usage in patients with advanced lung cancer treated by chemotherapy and/or radiotherapy.

Timeline

Start
2013-11
Primary completion
2016-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nadroparin Calcium Other / unclassified 0.4 ml Subcutaneous

Indications